首页> ESMO open> Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI.

导出 LinkOut

翻译打印收藏纠错

第一作者： A H S,Alig

第一单位： Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin. Electronic address: annabel.alig@charite.de.

作者： A H S,Alig ^[1] ; D P,Modest ^[2] ; S,Stintzing ^[2] ; K,Heinrich ^[3] ; M,Geissler ^[4] ; L,Fischer von Weikersthal ^[5] ; T,Decker ^[6] ; U,Vehling-Kaiser ^[7] ; S,Held ^[8] ; N,Moosmann ^[9] ; A,Stahler ^[2] ; A,Tannapfel ^[10] ; C,Giessen-Jung ^[2] ; A,Jung ^[11] ; L,Weiss ^[12] ; V,Heinemann ^[3]

作者单位： Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin. Electronic address: annabel.alig@charite.de. ^[1] Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin. ^[2] Department of Medicine III and Comprehensive Cancer Center, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), DKFZ, Heidelberg, Munich. ^[3] Hospital Karlsruhe, Karlsruhe. ^[4] Gesundheitszentrum St. Marien, Amberg. ^[5] Oncological Practice, Ravensburg. ^[6] ÜBAG MVZ Dr. Vehling-Kaiser GmbH, Landshut. ^[7] ClinAssess GmbH, Leverkusen. ^[8] Clinic Barmherzige Brüder Regensburg, Regensburg. ^[9] Institut für Pathologie der Ruhr-Universität Bochum, Bochum. ^[10] German Cancer Consortium (DKTK), DKFZ, Heidelberg, Munich; Institute of Pathology, University of Munich, Munich, Germany. ^[11] Department of Medicine III and Comprehensive Cancer Center, University Hospital, LMU Munich, Munich. ^[12]

关键词 BRAF mutation EGFR antibody metastatic colorectal cancer primary tumor location primary tumor sidedness